Biocon Biologics aims to raise $950 million through overseas bonds, with the sale managed by Standard Chartered Bank and HSBC, according to sources familiar ...

Biocon Biologics, a subsidiary of Biocon Ltd, has signed a 10-year deal with Eris Lifesciences to provide Metabolics, Oncology, and Critical Care products in ...